February 21, 2018
Cryoport serves the biopharmaceutical market with leading-edge logistics solutions for biologic materials to ensure a safe delivery, such as regenerative medicine, including immunotherapies, stem cells, and CAR-T cells. Cryoport's goal is to help simplify global cold chain logistics through innovative technollogy, unmatched monitoring and data capture and support for the life sciences industry. In a recent Contract Pharma article, Mark W. Sawicki, Ph.D., Chief Commercial officer of Cryoport, discusses the importance of Cryoport's leading-edge logistics services for the safe delivery of temperature-sensitive personalized medicines. Read more >
Tags: Clinical Trials Logistics, Temperature Controlled Logistics
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC